Pleural Mesothelioma

Pleural mesothelioma is a cancer that develops in the thin membrane (the pleura) lining the lungs and the inside of the chest wall. It is almost always caused by past inhalation of asbestos fibers, sometimes decades before symptoms appear. It is the most common form of mesothelioma, accounting for roughly 80–85% of cases.

Origin

The term combines "pleura," from the Greek for "side" or "rib," with "mesothelioma," coined in the early 20th century from "mesothelium" (the embryonic tissue layer that forms body cavity linings) plus "-oma" (tumor). The link between asbestos exposure and pleural mesothelioma was firmly established by Dr. J.C. Wagner's 1960 study of workers and residents near South African crocidolite mines.

Significance in Asbestos Context

For patients, a pleural mesothelioma diagnosis is both a serious medical event and a legal signal. This cancer is so strongly tied to asbestos that courts and medical authorities treat it as a "signature" disease of asbestos exposure. Diagnosis usually requires a tissue biopsy (not just imaging or fluid sampling) and immunohistochemistry to distinguish it from lung cancer or metastatic disease, so patients should ask whether their pathology was reviewed by a mesothelioma-experienced pathologist. Treatment decisions depend on the cell type (epithelioid, sarcomatoid, or biphasic) and stage, and these details, along with a careful occupational and household exposure history, will be central to both medical care and any legal claim.

Example Sentence

After months of shortness of breath and a persistent pleural effusion, a thoracoscopic biopsy confirmed that the retired pipefitter had epithelioid pleural mesothelioma linked to asbestos insulation work in the 1970s.

Related Terms

Mesothelioma, Pleura, Pleural Effusion, Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Pleural Plaques

Notes

• Request that your biopsy slides be reviewed by a pathologist experienced in mesothelioma; misdiagnosis as adenocarcinoma or reactive pleural disease is common at general hospitals.
• Ask your oncologist to document the specific histologic subtype (epithelioid, sarcomatoid, or biphasic) and stage. Both directly affect prognosis, treatment options, and claim valuation.
• Begin building a detailed exposure history now: jobs held, employers, products used, military service, secondhand ("take-home") exposure from a family member's work clothes, and any home renovation involving older insulation, drywall, or floor tiles.
• Preserve all medical records, imaging (CT scans, PET scans), pathology reports, and immunohistochemistry results. These are core evidence in both treatment planning and legal claims.
• Ask about referral to a high-volume mesothelioma center for evaluation of multimodal treatment (surgery such as pleurectomy/decortication or EPP, chemotherapy, immunotherapy, and clinical trials).